Novel postzygotic RASA1 mutation in a patient with Parkes Weber syndrome: A case report and literature review
Clinical Case Reports · 2024-11 · 12 (11)
DOI: 10.1002/ccr3.9543 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Case Reports, online erschienen am 03.11.2024. Verfasst von Robin A Pilz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics University Medicine Greifswald, and Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Key Clinical Message Not only germline but also postzygotic mutations in the RASA1 or EPHB4 genes can lead to capillary malformation‐arteriovenous malformation (CM‐AVM) syndrome. As it is not always possible to clinically distinguish between constitutional variants and postzygotic mosaicism, a sufficiently high sequencing depth must be used in genetic diagnostics to detect both. Abstract Capillary malformation‐arteriovenous malformation (CM‐AVM) syndrome, with or without Parkes Weber syndrome, is a rare autosomal dominant disease caused by pathogenic RASA1 or EPHB4 variants. Up to 80% of CM‐AVM cases have an affected parent. Gene panel sequencing was performed for a 4‐year‐old girl with multiple CMs, two capillary stains on the left leg, and associated overgrowth of the second toe. We also reviewed published cases with mosaic RASA1 and EPHB4 mutations. A mosaic RASA1 loss‐of‐function mutation was detected with a variant allele frequency (VAF) of 20% in the blood and oral epithelial cells of the index patient. The literature review illustrates that the severity of the clinical phenotype does not correlate with the VAF. We also identified a germline nonsense variant in the patient's TEK gene. However, inactivating TEK variants do not cause a vascular phenotype but can confer an increased risk for primary congenital glaucoma with variable expressivity. The case presented here illustrates that the choice of the sequencing depth of a diagnostic next‐generation sequencing test for CM‐AVM patients should always take mosaicism into account and that a good knowledge of the sequenced genes and associated disease mechanisms is necessary for adequate genetic counseling.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Human Genetics University Medicine Greifswald, and Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald Greifswald Germany.
- Limbach Genetics GmbH MVZ Humangenetik Frankfurt Germany.
- Institute for Molecular Medicine, MSH Medical School Hamburg Hamburg Germany.
ORCID-Profile: Matthias Rath
Zitieren
APA
Pilz, R. A., Skowronek, D., Ehresmann, T., Felbor, U., & Rath, M. (2024). Novel postzygotic RASA1 mutation in a patient with Parkes Weber syndrome: A case report and literature review. Clinical Case Reports, 12(11). https://doi.org/10.1002/ccr3.9543
Vancouver
Pilz RA, Skowronek D, Ehresmann T, Felbor U, Rath M. Novel postzygotic RASA1 mutation in a patient with Parkes Weber syndrome: A case report and literature review. Clinical Case Reports. 2024;12(11). doi:10.1002/ccr3.9543
BibTeX
@article{Pilz2024,
author = {Pilz, Robin A and Skowronek, Dariush and Ehresmann, Tamara and Felbor, Ute and Rath, Matthias},
title = {Novel postzygotic RASA1 mutation in a patient with Parkes Weber syndrome: A case report and literature review},
journal = {Clinical Case Reports},
year = {2024},
volume = {12},
number = {11},
doi = {10.1002/ccr3.9543}
}
EUVIMED